Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Book

Celiac Disease

In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan.
.
Affiliations
Free Books & Documents
Book

Celiac Disease

Sharon F. Daley et al.
Free Books & Documents

Excerpt

Celiac disease is an autoimmune disorder triggered by an immune-mediated response of the small intestine to dietary gluten, which is a protein found in wheat, barley, and rye. Although traditionally viewed as a gastrointestinal condition primarily associated with malabsorption, it is now more accurately classified as an autoimmune disorder with systemic manifestations. Celiac disease occurs in genetically predisposed individuals and results in a lifelong condition characterized by immune-mediated damage to the lining of the small intestine due to the immune response to gluten. This damage is evidenced by villous atrophy, crypt hyperplasia, and infiltration of the lamina propria by immune cells, which in turn leads to malabsorption of essential nutrients, including micronutrients, fat-soluble vitamins, iron, vitamin B12, and folate. Typical gastrointestinal symptoms include diarrhea, abdominal discomfort, bloating, and constipation. However, celiac disease can also present with extraintestinal manifestations such as fatigue, weight loss, skin rashes, anemia, and osteoporosis. Growth failure is a frequent additional symptom in children with celiac disease (see Image. Intestinal Changes in Celiac Disease).

Detection of disease-specific antibodies, such as anti-tissue transglutaminase (tTG)–immunoglobulin A (IgA) or "tTG-IgA" and anti-endomysial antibodies (EMAs), is a key initial step in diagnosing suspected celiac disease. Most patients require a small intestinal biopsy to confirm the diagnosis and assess the extent of mucosal damage. The only effective treatment for celiac disease is the strict and complete exclusion of gluten from the diet, which involves lifelong adherence to a strict gluten-free diet (GFD). Maintaining a GFD is essential for symptom resolution and the prevention of long-term complications, with most patients responding well to this dietary modification. Regular medical follow-up is necessary to monitor adherence and promptly identify and manage any disease-related complications.

PubMed Disclaimer

Conflict of interest statement

Disclosure: Sharon Daley declares no relevant financial relationships with ineligible companies.

Disclosure: Muhammad Haseeb declares no relevant financial relationships with ineligible companies.

References

    1. Tye-Din JA, Galipeau HJ, Agardh D. Celiac Disease: A Review of Current Concepts in Pathogenesis, Prevention, and Novel Therapies. Front Pediatr. 2018;6:350. - PMC - PubMed
    1. Austin K, Deiss-Yehiely N, Alexander JT. Diagnosis and Management of Celiac Disease. JAMA. 2024 Jul 16;332(3):249-250. - PubMed
    1. Yu XB, Uhde M, Green PH, Alaedini A. Autoantibodies in the Extraintestinal Manifestations of Celiac Disease. Nutrients. 2018 Aug 20;10(8) - PMC - PubMed
    1. Clark R, Johnson R. Malabsorption Syndromes. Nurs Clin North Am. 2018 Sep;53(3):361-374. - PubMed
    1. Sharma P, Baloda V, Gahlot GP, Singh A, Mehta R, Vishnubathla S, Kapoor K, Ahuja V, Gupta SD, Makharia GK, Das P. Clinical, endoscopic, and histological differentiation between celiac disease and tropical sprue: A systematic review. J Gastroenterol Hepatol. 2019 Jan;34(1):74-83. - PubMed

Publication types

LinkOut - more resources